Alopecia Areata: News on diagnosis, pathogenesis and treatment

Giornale Italiano di Dermatologia e Venereologia

Volumn 149, Issue 1, 2014, Pages 25-45

  D'Ovidio, R ^a  

^a Associazione Italiana Dermatologi Ambulatoriali   (Italy)

Author keywords

Alopecia areata, etiology; Diagnosis; Therapeutics

Indexed keywords

ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AUTOIMMUNE REGULATOR PROTEIN; CORTICOSTEROID; HEAT SHOCK PROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 21; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR FOXP3;

ALOPECIA AREATA; ANTIBIOTIC THERAPY; ANXIETY DISORDER; ATOPY; AUTOIMMUNE DISEASE; CATARACT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; EPILUMINESCENCE MICROSCOPY; EVIDENCE BASED MEDICINE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HAIR ROOT; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; MONONUCLEOSIS; NAIL DISEASE; NATURAL KILLER CELL; PATHOGENESIS; PROGNOSIS; REGULATORY T LYMPHOCYTE; REVIEW; SCALP HAIR; SEASONAL VARIATION; SYSTEMIC THERAPY; T LYMPHOCYTE ACTIVATION; TOPICAL TREATMENT; ULTRAVIOLET B RADIATION; VITILIGO;

ALOPECIA AREATA; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CATARACT; COMBINED MODALITY THERAPY; COMORBIDITY; DERMATOLOGIC AGENTS; DERMOSCOPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAIR COLOR; HAIR FOLLICLE; HLA-D ANTIGENS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOTHERAPY; INFECTION; MALE; MENTAL DISORDERS; NAIL DISEASES; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 84899073790     PISSN: 03920488     EISSN: 18271820     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. Rantuccio F, Mastrolonardo M, Conte A. Area Celsi. Osservazioni personali e revisione della letteratura. G Ital Dermatol Venereol 1995;130:23-35.
2. D'Ovidio R. Aggiornamenti sul pelo a punto esclamativo. Dermatologia Ambulatoriale 2000;3:39-40.
3. Van Scott EJ. Response of hair roots to chemicals and physical influence. In: "The biology oh hair growth". Montagna Ed. Academic Press; 1958. p. 441-9.
4. Whiting DA. Histopathologic feature of Alopecia Areata. A new look. Arch Dermatol 2003;139:1555-9. (Pubitemid 37523073)
5. Tosti A, Whiting D, Iorizzo M, Pazzaglia M, Misciali C, Vincenzi C et al. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol 2008;59: 64-7.
6. D'Ovidio RR. Prognosi delle alopecie in chiazze. Dermatologia Ambulatoriale 2005;4:12-9.
7. Jellinek JE. Sudden whitening of the hair. Bull New York Acad Med 1972;48:1003.
8. Del Río E. Targetoid hair regrowth in alopecia areata: the wave theory. Arch Dermatol 1998;134:1042-3. (Pubitemid 28385338)
9. Sato-Kawamura M, Aiba S, Tagami H. Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis. Dermatology 2002;205:367-73. (Pubitemid 35356764)
10. Anderson I. Alopecia areata. A clinical study. Br Med J 1950;2:1250-2.
11. Rebora A. Acute diffuse and total alopecia of the female scalp: a new subtype of diffuse alopecia areata that has a favorable prognosis - a reply. Dermatology 2003;207:339
12. Rebora A. Alopecia areata incognita: a hypothesis. Dermatologica 1987;174:214-8. (Pubitemid 17052563)
13. Gilhar A, Keren A, Shemer A, d'Ovidio R, Ullmann Y, Paus R. Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. J Invest Dermatol 2013;133:844-7.
14. Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: frequency and clinical presentation. JEADV 2009;23:169-243.
15. Summerly R, Watson DM. Copeman PWM. Alopecia areata and cataracts. A.M.A. Arch Dermatol 1966;93:411.
16. Pandhi D, Singal A, Gupta R, Das G. Ocular alterations in patients of alopecia areata. J Dermatol 2009;36:262-8.
17. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000;165:7323-9. (Pubitemid 32001213)
18. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol 200;117:1357-62.
19. Ucak H, Soylu E, Ozturk S, Demir B, Cicek D, Erden I et al. Audiological abnormalities in patients with alopecia areata. J Eur Acad Dermatol Venereol 2013 [Epub ahead of print].
20. Laakso SM, Laurinolli TT, Rossi LH, Lehtoviita A, Sairanen H, Perheentupa J et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J Autoimmun 2010;35:351-7.
21. Nieves DS, Phipps RP, Pollock SJ, Ochs HD, Zhu Q, Scott GA et al. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 2004;140:466-72. (Pubitemid 38469251)
22. Conteduca G, Rossi A, Megiorni F, Parodi A, Ferrera F, Tardito S et al. Single nucleotide polymorphism in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata associated with Alopecia Areata. Clin Exp Med 2012 [Epub ahead of print].
23. Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME et al. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4. Clin Exp Dermatol 2006;31:746-9. (Pubitemid 44086827)
24. Grandolfo M, Biscazzi AM, Pipoli M. Alopecia areata and autoimmunity. G Ital Dermatol Venereol 2008;143:277-81.
25. Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M et al. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol 2010;130:93-101.
26. Gilhar A, Paus R, Kalish S. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J. Clin. Invest 2007; 117: 2019-27 (Pubitemid 47219540)
27. Fanti PA, Tosti A, Bardazzi F, Guerra L, Morelli R et al. Alopecia areata. A pathological study of nonresponder patients. Am J Dermatopathol 1994;16:167-70. (Pubitemid 24121264)
28. D'Ovidio R, Di Prima T. A possible continuum from reversibile to irreversibile forms of alopecia. Hair Therap Transplantat 2013,3:106-9.
29. Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm 2010;2010:928030.
30. Kalish RS, Gilhar A. Alopecia areata: autoimmunity - the evidence is compelling. J Investig Dermatol Symp Proc 2003;8:164-7. (Pubitemid 37222823)
31. Marhaba R, Vitacolonna M, Hildebrand D, Baniyash M, Freyschmidt-Paul P et al. The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J Immunol 2007;179:5071-81.
32. Tembhre MK, Sharma VK. T-helper and regulatory T-cell cytokines in peripheral blood of patients with active alopecia areata. Br J Dermatol 2013;169:543-8.
33. Bröcker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987;88:564-8. (Pubitemid 17068964)
34. Gilhar A. Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol 2010;130:2535-7.
35. Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P et al. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Eur J Immunol 2012:1833-42.
36. Blauvelt A, Asada H, Klaus-Kovtun V, Altman DJ, Lucey DR, Katz SI. Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol 1996:1047-52. (Pubitemid 26155099)
37. Jabbari A, Dai Z, Xing L, de Jong A, Christiano AM, Clynes R. Reversal of longstanding alopecia areata in C3H/HeJ mice using topical JAK inhibitors. Poster at 7th World Congress for Hair Research 2-4 May 2013 J Invest Dermatol 2013;133:1391-439.
38. Bystryn JC, Orentreich N, Stengel F. Direct Immunofluorescence studies in alopecia areata and male pattern alopecia. J Invest Dermatol 1979;73:317-20. (Pubitemid 10165032)
39. Igarashi R, Takeuchi S, Sato Y. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata. Acta Derm Venereol 1980;60:33-7. (Pubitemid 10201654)
40. Tobin DJ, Gardner SH, Luther PB, Dunston SM, Lindsey NJ et al. A natural canine homologue of alopecia areata in humans. Br J Dermatol 2003;149:938-50. (Pubitemid 37541977)
41. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010;466:113-7.
42. Zlotogorski A, Weinrauch L, Brautbar C. Familial alopecia areata: no linkage with HLA. Tissue Antigens 1990;36:40-1. (Pubitemid 20270519)
43. Megiorni F, Pizzuti A, Mora B, Rizzuti A, Garelli V, Maxia C et al. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol 2011;165:823-7.
44. O'Brien RM, Thomas WR, Nicholson I, Lamb JR, Tait BD. An immunogenetic analysis of the T-cell recognition of the major house dust mite allergen Der p 2: identification of high-and low-responder HLA-DQ alleles and localization of T-cell epitopes. Immunology 1995;86:176-82.
45. Camponeschi B, Lucarelli S, Frediani T, Barbato M, Quinteri F. Association of HLA-DQ7 antigen with cow milk protein allergy in Italian children. Pediatr Allergy Immunol 1997;8:106-9. (Pubitemid 27483087)
46. Xiao FL, Zhou FS, JB Liu, Yan KL, Cui Y, Gao M et al. Association of HLA-DQA1 and DQB1 alleles with alopecia areata in Chinese Hans. Arch Dermatol Res 2005;297:201-9. (Pubitemid 41618699)
47. Gao J, Lin Y, Qiu C, Liu Y, Ma Y, Liu Y. Association between HLA-DQA1,-DQB1gene polymorphisms and susceptibility to asthma in northern Chinese subjects.Chin Med J 2003;116:1078-82. (Pubitemid 36975165)
48. John KK, Brockschmidt FF, Redler S, Herold C, Hanneken S, Eigelshoven S et al. Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol 2011;131:1169-72.
49. Bhanusali DG, Sachdev A, Olson MA, Gerlach JA, Sinha AA. PTPN22 profile indicates a novel risk group in Alopecia areata. Hum Immunol 2013 [Epub ahead of print],
50. Offidani A, Amerio P, Bernardini ML, Feliciani C, Bossi G. Role of 50 cytomegalovirus replication in alopecia areata pathogenesis. J Cutan Med Surg 2000;4:63-5. (Pubitemid 30234935)
51. Rodriguez TA, Duvic M; National Alopecia Areata Registry. Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis. J Am Acad Dermatol 2008;59:137-9.
52. D'Ovidio R, D'Ovidio F. Recidive stagionali nell'alopecia areata. G Ital Dermatol Venereol 1995;130:295-9.
53. D'Ovidio R, Vessio M, d'Ovidio FD. Reduced level of vitamin D in chronic/relapsing alopecia areata. Dermato-Endocrinology 2013;5:271-3.
54. Cosman D, Müllberg J, Sutherland CL, Chin W, Armitage R, Fanslow W et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001;14:123-33. (Pubitemid 32206515)
55. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009;155:1-15.
56. Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007;27:87-95. (Pubitemid 46909247)
57. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007;21:921-8. (Pubitemid 47103722)
58. De Waard-van der Spek FB, Oranje AP, De Raeymaecker DM, Peereboom-Wynia JD et al. Juvenile versus maturity onset al.opecia areata: a comperative retrospective clinical study. Clin Exp Dermatol 1989;14:429-33. (Pubitemid 19278989)
59. Willemsen R, Vanderlinden J, Roseeuw D, Haentjens P. Increased history of childhood and lifetime traumatic events among adults with alopecia areata. J Am Acad Dermatol 2009;60:388-93.
60. Koo JYM, Shellow WVR, Hallman CP. Alopecia areata and increased prevelance of psychiatric disorders. Int J Dermatol 1994;33:849-50. (Pubitemid 24374072)
61. Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF et al. Psychosomatic factors in first-onset a.opecia areata. Psychosomatics 2003,44:374.
62. Picardi A, Battisti F, Tarsitani L, Baldassari M, Copertaro A, Mocchegiani E et al. Attachment security and immunity in healthy women. Psychosom Med 2007;69:40-6. (Pubitemid 46148363)
63. Solerte SB, Precerutti S, Gazzaruso C, Locatelli E, Zamboni M, Schifino N et al. Defect of a subpopulation of NK immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur J Endocrinol 2005;152:703-12. (Pubitemid 40744538)
64. Ott J, Pecnik P, Promberger R, Pils S, Seemann R, Hermann M, Frigo P. Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto's thyroiditis. Climacteric 2013 [Epub ahead of print].
65. Kaufman G, d'Ovidio R, Kaldawy A, Assy B, Ullmann Y, Etzioni A et al. An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b + T cells pathogenic? Exp Dermatol 2010;19:E347-9.
66. Thies W. Über die Morphologie des vegetativen Nervensystems in der menschlichen Haut nebst Untersuchung über neuropathologische Veränderungen bei verschiedenen Hautkrankheiten. VI Mitteilung Alopecia Areata Z Haut Geschlechtskr 1960;28:47-52.
67. Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 2002;168:6128-35. (Pubitemid 34620030)
68. Puchalsky Z. Anxiety structure and catecholamine parameters in patients with rosacea, alopecia areata and lichen ruber planus. Z Hautkr 1986;61:137-45.
69. Bosch JA, Berntson GG, Cacioppo JT, Marucha PT. Differential mobilization of functionally distinct nk subsets during acute psychologic stress. Psychosom Med 2005;67:366-75. (Pubitemid 40727149)
70. D'Ovidio R, d'Ovidio FD. Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: is it a primitive and pathogenic perturbation of hypothalamic- pituitary-adrenal axis? Int J Trichology 2011;3:43-4.
71. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP. Developmental neurobiology of childhood stress and trauma. Psychiatr Clin North Am 2002;25:397-426. (Pubitemid 34761244)
72. Jeckel CM, Lopes RP, Berleze MC, Luz C, Feix L et al. Neuroendocrine and immunological correlates of chronic stress in 'strictly healthy' populations. Neuroimmunomodulation 2010;17:9-18.
73. Hazeldine J, Arlt W, Lord JM. Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol 2010;120:127-36.
74. Courtois M, Loussouarn G, Hourseau S, Grollier JF. Periodicity in the growth and shedding of hair. Br J Dermatol 1996;134:47-54. (Pubitemid 26029663)
75. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010;9:709-15.
76. D'Ovidio R. Inflammatory alopecia: a hidden cause of an announced surgical failure. The Importance of Koebner Phenomenon in Trichology Hair Ther Transplant 2011;1:1
77. Wikramanayake TC, Villasante AC, Mauro LM, Perez CI, Schachner LA, Jimenez JJ. Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones 2011;15:985-91.
78. Herbert MK, Holzer P. Neurogenic inflammation. I. Basic mechanisms,physiology and pharmacology. Anasthesiol Intensivmed Notfallmed Schmerzther 2002;37:314-25. (Pubitemid 34662893)
79. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B et al. Mast cells and inflammation. Biochim BiophysActa 2010;1822:21-33.
80. Calvo CF, Chavanel G, Senik A. Substance P enhances IL-2 expression in activated human T cells. J Immunol 1992;148:3498-504.
81. Toyoda M, Makino T, Kagoura M, Morohashi M. Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study. Br J Dermatol 2001;144:46-54. (Pubitemid 32154592)
82. Toruniowa B, Jablonska S. Mast cells in the initial stages of psoriasis. Arch Dermatol Res 1988;280:189-93.
83. D'Ovidio R, Vena GA, Angelini G. Possibile ruolo immunopatologenetico dei mastociti nell'alopecia areata. G It Dermat Vener 1988;123:569-70.
84. Cetin ED, Savk E, Uslu M, Eskin M, Karul A. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 2009;31:53-60.
85. Theoharis C, Theoharides PHD. Mast cells and stress a psychoneuroimmunological perspective. J Clin Psychopharmacol 2002;22:103-8
86. Tejedor Alonso MA, Sastre Dominguez J, Sánchez-Hernández JJ, PérezFrances C,Hoz de la Caballer B. Clinical and functional differences among patients with idiopathic anaphylaxis. J Investig Allergol Clin Immunol 2004;14:177-86. (Pubitemid 39390273)
87. D'Ovidio R. Koebner phenomenon in alopecia areata: rapid appearance after trichogram - implications for pathogenesis and therapy. G It Dermat Vener 2013;148:225-9.
88. Happle R, van der Steen PHM, Perret CM. The Renbok phenomenon: An inverse Koebner reaction observed in alopecia areata. Eur J Dermatol 1991;2:39-40.
89. Zhang B, Zhao Y, Cai Z, Caulloo S, McElwee KJ, Li Y, Chen X, Yu M, Yang J, Chen. Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum. Australas J Dermatol 2013;54:184-91.
90. Ikeda T. A new classification of alopecia areata. Dermatologica 1965;131:421-45.
91. Sulen JC, Stolte LAM, Bakker JAJ, Verboom E. Alopecia areata. Acta Endocrinologica 1956;23:60-71
92. Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients, J Am Acad Dermatol 2006;55:438-41. (Pubitemid 44189598)
93. Rodriguez TA, Fernandes KE, Dresser KL, Duvic M. National Alopecia Areata Registry. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol 2010;62:525-7.
94. Fabbrocini G, Panariello L, De Vita V, Vincenzi C, Lauro C, Nappo D et al. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol 2012 [Epub ahead of print].
95. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;CD004413.
96. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia Areata update: part II. Treatment. J Am Acad Dermatol 2010;62:191-202.
97. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012;166:916-26.
98. Ito T. Advances in the management of alopecia areata. J Dermatol 2012;39:11-7.
99. Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM. Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007-22. (Pubitemid 17176816)
100. Kibar M, Aktan S, Lebe B, Bilgin M. Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients. Australas J Dermatol 2013 [Epub ahead of print],
101. Ono S, Otsuka A, Yamamoto Y, Kataoka TR, Koyanagi I, Miyachi Y et al. Serum granulysin as a possible key marker of the activity of alopecia areata. J Dermatol Sci 2013 [Epub ahead of print].
102. Wiseman MC, Shapiro J, MacDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 2001;137:1063-8 (Pubitemid 32756464)
103. Gulati N, Suárez-Fariñas M, Gilleaudeau P, Sullivan-Whalen M,Cueto I, Mitsui H et al. Topical diphencyprone (DPCP) induces distinct early and late cellular immune reactions in human skin. J Invest Dermatol 2013;133:S159-S190.
104. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003;49:96-8. (Pubitemid 36801639)
105. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006;212:361-5.
106. Inui S, Nakajima T, Toda N, Itami S. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. J Dermatol 2009;36:323-7.
107. Yoshizawa Y, Kawana S. Efficacy of Ebastine in the treatment of alopecia areata. Japanese J Dermatol 2005;15:1473-80.
108. Forward NA, Furlong SJ, Yang Y, Lin TJ, Hoskin DW. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.J Immunol 2009;183:3014-22.108.
109. Rangwala S, Rashid RM. Alopecia: a review of laser and light therapies.Dermatol Online J 2012;18:3.
110. Bondavalli P, Quadri G, Parodi A, Rebora A. Failure of gluten-free diet in celiac disease-associated alopecia areata. Acta Derm Venereol 1998;78:319 (Pubitemid 28328944)
111. Simopoulos, Artemis P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002:495-505.
112. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004;229:1136-42. (Pubitemid 39602256)
113. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;25;496:518-22.
114. D'Ovidio R, Vessio M, D'Ovidio FD. Reduced level of vitamin D in chronic / relapsing alopecia areata. Poster at 7th World Congress for Hair Research 2-4 May 2013 J Invest Dermatol 2013;133:1391-439.
115. Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011;17:3165-70.
116. Abdel Hafez HZ, Mahran AM, Hofny EM, Attallah DA, Sayed DS, Rashed H. Alopecia areata is not associated with Helicobacter pylori. Indian J Dermatol 2009;54:17-9.
117. Liakopoulou M, Alifieraki T, Katideniou A, Kakourou T, Tselalidou E, Tsiantis J et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997;36:678-84. (Pubitemid 27184076)
118. García-Hernández MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F. Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999;26:625-32. (Pubitemid 29510343)
119. Perini G, Zara M, Cipriani R, Carraro C, Preti A et al. Imipramine in alopecia areata. A double-blind, Placebo-Controlled study. Psychoter Psycosom 1994;61:195-8. (Pubitemid 24132931)
120. Ricciardi A, Ruberto A, García-Hernández MJ, Kotzalidis GD, Trevisi M, Persechino S et al. Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment. J Eur Acad Dermatol Venereol 2006;20:1000-1.
121. Feldmann KA, Kunte C, Wollenberg A, Wolfe H. Is topical tacrolimus effective in alopecia areata universalis? Br J Dermatol 2002;147:1031-2 (Pubitemid 35365464)
122. Ucak H, Kandi B, Cicek D, Halisdemir N, Dertlioǧlu SB. The comparison oftreatment with clobetasol propionate 0,05% and 1% topical pimecrolimus treatmen in the treatment of alopecia areata. J dermatolog Treat 2012;23:410-20.
123. Petukhova L, Cabral RM, Mackay-Wiggan J, Clynes R, Christiano AM. The genetics of alopecia areata: What's new and how will it help our patients? Dermatol Ther 2011;24:326-36.
124. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013;7:67.
125. Trink A, Sorbellini E, Bezzola P, Rodella L, Rezzani R, Ramot Y et al. A randomized, double-blind, placebo and active-controlled, half-head study toevaluate the effects of platelet rich plasma on alopecia areata. Br J Dermatol 2013;169:690-4.
126. Dai Z, Xing L, Jabbari A, de Jong A, Christiano AM, Clynes R. Type I cytokines and chemokines are targetable immune pathways in alopecia areata. Poster at 7th World Congress for Hair Research 2-4 May 2013. J Invest Dermatol 2013;133:1391-439.
127. Zlotogorski A. Communication at 7th World Congress for Hair Research 2-4 May 2013.
128. Gilhar A, Keren A, Shemer A, Ullmann Y, Paus R. Blocking potassium channels (kv1.3): a new treatment option for alopecia areata? J Invest Dermatol 2013;133:2088-91.
129. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med 2012;366:1515-25.